Endokrynologia Polska最新文献

筛选
英文 中文
The antifracture efficacy of vitamin D in adults - are we assessing it reliably? A systematic review. 维生素D对成年人的防冻功效——我们是否可靠地评估它?系统的回顾。
Endokrynologia Polska Pub Date : 2023-01-01 Epub Date: 2023-10-02 DOI: 10.5603/ep.95639
Jerzy Przedlacki, Urszula Ołdakowska-Jedynak
{"title":"The antifracture efficacy of vitamin D in adults - are we assessing it reliably? A systematic review.","authors":"Jerzy Przedlacki,&nbsp;Urszula Ołdakowska-Jedynak","doi":"10.5603/ep.95639","DOIUrl":"10.5603/ep.95639","url":null,"abstract":"<p><strong>Introduction: </strong>The antifracture efficacy of vitamin D is still controversial. The aim of this systematic review was to examine if the vitamin D trials were designed adequately to reliably assess its antifracture activity.</p><p><strong>Material and methods: </strong>The electronic databases PubMed, Medline, Embase, Web of Science, and Cochrane Library were searched to identify clinical trials evaluating the antifracture efficacy of vitamin D in adults. We compared the protocols of the trials against the opinions of the American Society for Bone and Mineral Research (ASBMR), International Society for Clinical Densitometry (ISCD), National Osteoporosis Foundation (NOF), European Medicines Agency (EMEA) experts, and the consensus statement from the 2nd International Conference on Controversies in Vitamin D, and against the protocols of the trials of the medications with proven antifracture efficacy (bisphosphonates, teriparatide, abaloparatide, raloxifene, denosumab, romosozumab). We assessed the prospective character, study design, group description, number of patients, study duration, and vitamin D (serum examination and dosage) supplementation. A description of the desired characteristics of the study protocol was presented.</p><p><strong>Results: </strong>Thirteen eligible trials were identified. All but 2 were conducted in the elderly population only. Nine trials were included in the final analysis. Serum 25-hydroxy vitamin D (25OHD) was not measured in a representative number of subjects before (except in 2 studies), during, or after treatment in any study.</p><p><strong>Conclusions: </strong>The analysed studies did not conclusively assess the vitamin D antifracture efficacy in patients with prestudy low serum vitamin levels, due to the lack of assessment of whether sufficient doses of vitamin D were used. They informed about the relevant doses and preparations of vitamin D in particular groups (specific fracture risk, age, place of residence) only.</p>","PeriodicalId":93990,"journal":{"name":"Endokrynologia Polska","volume":" ","pages":"499-510"},"PeriodicalIF":0.0,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"41155591","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Angiotensin (1-7) reverses glucose-induced islet β cell dedifferentiation by Wnt/β-catenin/FoxO1 signalling pathway. 血管紧张素(1-7)通过Wnt/β-catenin/FoxO1信号通路逆转葡萄糖诱导的胰岛β细胞去分化。
Endokrynologia Polska Pub Date : 2023-01-01 Epub Date: 2023-10-02 DOI: 10.5603/ep.94750
Dandan Guo, Junhua He, Hao Guo, Guoning Song, Lina Peng, Min An, Caixia Wang
{"title":"Angiotensin (1-7) reverses glucose-induced islet β cell dedifferentiation by Wnt/β-catenin/FoxO1 signalling pathway.","authors":"Dandan Guo,&nbsp;Junhua He,&nbsp;Hao Guo,&nbsp;Guoning Song,&nbsp;Lina Peng,&nbsp;Min An,&nbsp;Caixia Wang","doi":"10.5603/ep.94750","DOIUrl":"10.5603/ep.94750","url":null,"abstract":"<p><strong>Introduction: </strong>Recent studies have shown that a decline in isletβ cells quality is due to β-cell dedifferentiation, not only β-cell apoptosis. Angiotensin (1-7) [Ang(1-7)] could attenuate high glucose-induced apoptosis and dedifferentiation of pancreaticβ cells by combining with MAS receptors. However, the mechanism of such action has not been elucidated. Recent studies have revealed that Wnt/β-catenin and forkhead box transcription factor O1 (FoxO1) are associated with β-cell dedifferentiation. Our study aims to explore whether the effects of Ang(1-7)on islet b cell dedifferentiation are mediated through the Wnt/β-catenin/FoxO1 pathway.</p><p><strong>Material and methods: </strong>Isletβ cells were divided into 6 groups: a control group, a high-glucose group, high glucose with Ang(1-7) group, high-glucose with Ang(1-7) and A779 group, high-glucose with angiotensin(1-7) and CHIR99021 group, and high-glucose with CHIR99021 group. A779 is a kind of MAS receptor antagonist that blocks the action of Ang(1-7), and CHIR99021 is a Wnt pathway activator. The morphology of pancreaticβ cells was observed in each group after 48 hours of intervention. β-cell insulin secretory function and expressions of relevant factors were measured.</p><p><strong>Results: </strong>Compared with the control group, the cell morphology became degraded in the high-glucose group and the capability of insulin secretion was reduced. Meanwhile, the expressions of matureβ cells markers [pancreatic and duodenal homeobox 1 (Pdx1) and MAF BZIP transcription factor A (MafA)] were reduced, while the expressions of endocrine progenitor cells makers [octamer-binding transcription factor 4 (Oct4) and Nanog] were increased. The addition of CHIR99021 resulted in profound deep destruction ofβ cells compared with the high-glucose group. However, such changes were dramatically reversed following the treatment of Ang(1-7). The addition of A779 significantly inhibited the improvement caused by Ang(1-7).</p><p><strong>Conclusion: </strong>Ang(1-7) can effectively reverseβ cell dedifferentiation through Wnt/β-catenin/FoxO1 pathway. It might be a new strategy for preventing and treating diabetes.</p>","PeriodicalId":93990,"journal":{"name":"Endokrynologia Polska","volume":" ","pages":"544-552"},"PeriodicalIF":0.0,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"41175862","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Delayed symptomatic cerebral vasospasm after transsphenoidal resection of pituitary adenoma. 垂体腺瘤经蝶切除术后迟发性症状性脑血管痉挛。
Endokrynologia Polska Pub Date : 2023-01-01 Epub Date: 2023-10-02 DOI: 10.5603/ep.95790
Michał Senger, Tomasz Andrzej Dziedzic, Magdalena Góralska, Tomasz Gotlib, Przemysław Kunert
{"title":"Delayed symptomatic cerebral vasospasm after transsphenoidal resection of pituitary adenoma.","authors":"Michał Senger,&nbsp;Tomasz Andrzej Dziedzic,&nbsp;Magdalena Góralska,&nbsp;Tomasz Gotlib,&nbsp;Przemysław Kunert","doi":"10.5603/ep.95790","DOIUrl":"10.5603/ep.95790","url":null,"abstract":"Not required for Clinical Vignette.","PeriodicalId":93990,"journal":{"name":"Endokrynologia Polska","volume":" ","pages":"561-562"},"PeriodicalIF":0.0,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"41170889","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Primary thyroid smooth muscle tumour. 原发性甲状腺平滑肌肿瘤。
Endokrynologia Polska Pub Date : 2023-01-01 Epub Date: 2023-11-23 DOI: 10.5603/ep.96728
Jian Jiao, Fan Yang, Yuan Zhang, Feng-Jin Shang, Bu-Qiang Wu
{"title":"Primary thyroid smooth muscle tumour.","authors":"Jian Jiao, Fan Yang, Yuan Zhang, Feng-Jin Shang, Bu-Qiang Wu","doi":"10.5603/ep.96728","DOIUrl":"10.5603/ep.96728","url":null,"abstract":"<p><p>Not required for Clinical Vignette.</p>","PeriodicalId":93990,"journal":{"name":"Endokrynologia Polska","volume":" ","pages":""},"PeriodicalIF":0.0,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"138296824","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Could a nonfunctional adrenal incidentaloma be a risk factor for increased carotid intima-media thickness and 10-year cardiovascular mortality based on the SCORE algorithm? A study from a single centre in Poland. 基于SCORE算法,非功能性肾上腺偶发瘤可能是颈动脉内膜-中膜厚度增加和10年心血管死亡率增加的危险因素吗?一项来自波兰一个中心的研究。
Endokrynologia Polska Pub Date : 2023-01-01 Epub Date: 2023-11-23 DOI: 10.5603/ep.95139
Magdalena Szychlińska, Magdalena Rzeczkowska, Wojciech Matuszewski, Elżbieta Bandurska-Stankiewicz
{"title":"Could a nonfunctional adrenal incidentaloma be a risk factor for increased carotid intima-media thickness and 10-year cardiovascular mortality based on the SCORE algorithm? A study from a single centre in Poland.","authors":"Magdalena Szychlińska, Magdalena Rzeczkowska, Wojciech Matuszewski, Elżbieta Bandurska-Stankiewicz","doi":"10.5603/ep.95139","DOIUrl":"10.5603/ep.95139","url":null,"abstract":"<p><strong>Introduction: </strong>Adrenal incidentaloma (AI) secreting small amounts of glucocorticoids may cause morphological and functional changes in the blood vessels. Early stages of cardiovascular remodeling may be observed among asymptomatic patients with AI. But it is unclear whether the nonfunctional adrenal incidentalomas (NFAI) may also be a risk factor for cardiovascular diseases. The aim of this study was to determine the relationship between NFAI, carotid intima-media thickness (CIMT), and cardiovascular risk (CVR) based on Systematic Coronary Risk Evaluation (SCORE) prediction models for Europe.</p><p><strong>Material and methods: </strong>This study from a single centre in Poland included 48 NFAI patients and 44 individuals in the control group matched for age, sex, and body mass index (BMI). All participants underwent adrenal imaging, biochemical evaluation, measurement of CIMT, and assessment of the 10-year risk of cardiovascular mortality based on the SCORE algorithm. Hormonal evaluation was conducted in AI patients.</p><p><strong>Results: </strong>The NFAI group showed significantly higher sodium (p = 0.02) and glucose levels in the 2-h oral glucose tolerance test (OGTT) (p = 0.04), a higher CIMT (p < 0.01), and a higher CVR calculated according to the SCORE algorithm (p = 0.03). The estimated glomerular filtration rate (eGFR) was higher in the NFAI group (p = 0.015). Hypertension (p < 0.01) and IGT (p = 0.026) were more common in the NFAI group. Statistically significant positive correlations were found between CIMT and age (r = 0.373, p = 0.003), waist circumference (r = 0.316, p = 0.029), diastolic blood pressure (r = 0.338, p = 0.019), and CVR based on the SCORE algorithm (r = 0.43, p = 0.004). There was a statistically significant positive correlation between CIMT and serum cortisol levels after 1 mg dexamethasone suppression test (r = 0.33, p = 0.02).</p><p><strong>Conclusion: </strong>Non-functional adrenal adenomas are associated with increased CIMT and CVR. Early stages of cardiovascular remodelling can be observed in asymptomatic NFAI patients.</p>","PeriodicalId":93990,"journal":{"name":"Endokrynologia Polska","volume":" ","pages":""},"PeriodicalIF":0.0,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"138296819","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Eagle's syndrome mimicking thyroid-associated orbitopathy. 类似甲状腺相关眼眶病的伊格尔综合征。
Endokrynologia Polska Pub Date : 2023-01-01 Epub Date: 2023-10-02 DOI: 10.5603/ep.96351
Martyna Dziedzic, Grzegorz Sokołowski, Alicja Hubalewska-Dydejczyk, Małgorzata Trofimiuk-Müldner
{"title":"Eagle's syndrome mimicking thyroid-associated orbitopathy.","authors":"Martyna Dziedzic,&nbsp;Grzegorz Sokołowski,&nbsp;Alicja Hubalewska-Dydejczyk,&nbsp;Małgorzata Trofimiuk-Müldner","doi":"10.5603/ep.96351","DOIUrl":"10.5603/ep.96351","url":null,"abstract":"<p><p>Not required for Clinical Vignette.</p>","PeriodicalId":93990,"journal":{"name":"Endokrynologia Polska","volume":" ","pages":"536-564"},"PeriodicalIF":0.0,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"41162814","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Adipose tissue as a cause of endocrine dysfunction. 脂肪组织作为内分泌功能障碍的原因。
Endokrynologia Polska Pub Date : 2023-01-01 DOI: 10.5603/ep.95378
Alina Ewa Kuryłowicz
{"title":"Adipose tissue as a cause of endocrine dysfunction.","authors":"Alina Ewa Kuryłowicz","doi":"10.5603/ep.95378","DOIUrl":"https://doi.org/10.5603/ep.95378","url":null,"abstract":"<p><p>Adipose tissue is a large hormonally active organ that secretes several substances (adipokines), and an important site for the synthesis and metabolism of steroid hormones. With energy balance, the secretory and metabolic activity of adipose tissue determines the normal function of many organs, including the endocrine glands. However, in the course of overweight and obesity, adverse changes occur in the structure and function of adipocytes. Obesity-related adipose tissue dysfunction translates into a change in the profile of secreted adipokines, and it impairs steroidogenesis. These phenomena contribute to the development of obesity-related complications, which also affect the major tropic axes regulating the endocrine glands. However, there is increasing evidence that weight reduction is an effective treatment for obesity-related adipose tissue dysfunction, thereby restoring endocrine function. This narrative review presents the impact of adipose tissue on endocrine gland activity both in the physiological state and in obesity-related dysfunction. It also discusses how functional (related to excess adiposity) changes in the endocrine system can be restored with effective treatment of obesity.</p>","PeriodicalId":93990,"journal":{"name":"Endokrynologia Polska","volume":"74 5","pages":"468-479"},"PeriodicalIF":0.0,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"71416335","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Secondary hyperparathyroidism in chronic kidney disease: pathomechanism and current treatment possibilities. 慢性肾脏疾病继发性甲状旁腺功能亢进:病理机制和目前治疗的可能性。
Endokrynologia Polska Pub Date : 2023-01-01 DOI: 10.5603/ep.95820
Małgorzata Rodzoń-Norwicz, Sebastian Norwicz, Magdalena Sowa-Kućma, Agnieszka Gala-Błądzińska
{"title":"Secondary hyperparathyroidism in chronic kidney disease: pathomechanism and current treatment possibilities.","authors":"Małgorzata Rodzoń-Norwicz,&nbsp;Sebastian Norwicz,&nbsp;Magdalena Sowa-Kućma,&nbsp;Agnieszka Gala-Błądzińska","doi":"10.5603/ep.95820","DOIUrl":"https://doi.org/10.5603/ep.95820","url":null,"abstract":"<p><p>Secondary hyperparathyroidism (SHPT) is one of the most common metabolic complications resulting from chronic kidney disease (CKD). The complexity of calcium and phosphate disorders associated with CKD is defined by the Kidney Disease Improvement Global Outcomes (KDIGO) working group as CKD-related mineral and bone disorders (CKD-MBD). The last update of the KDIGO guidelines on the conduct in CKD-MBD was published in 2017. The treatment of SHPT is based on 2 strategies: counteracting hyperphosphataemia and suppressing parathyroid hormone (PTH) secretion. Therapy should be based on optimally selected drugs, taking into account additional effects to reduce the risk of chronic complications and side effects. The creation of new drugs with a better safety profile, significant reduction of side effects, and greater efficiency in achieving target serum phosphorus and PTH values forces the gradual replacement of existing treatment with new pharmacotherapies. The aim of this study is to discuss the latest issues (in connection with the latest KDIGO guidelines) regarding the pathomechanism of secondary hyperparathyroidism and the current directions of the therapy in these disorders.</p>","PeriodicalId":93990,"journal":{"name":"Endokrynologia Polska","volume":"74 5","pages":"490-498"},"PeriodicalIF":0.0,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"71416339","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Insulin autoimmune syndrome. 胰岛素自身免疫综合征
Endokrynologia Polska Pub Date : 2023-01-01 Epub Date: 2023-11-23 DOI: 10.5603/ep.95669
Mikołaj Radziszewski, Magdalena Iwaniuk, Marek Rosłon, Agnieszka Kondracka, Janusz Pachucki
{"title":"Insulin autoimmune syndrome.","authors":"Mikołaj Radziszewski, Magdalena Iwaniuk, Marek Rosłon, Agnieszka Kondracka, Janusz Pachucki","doi":"10.5603/ep.95669","DOIUrl":"10.5603/ep.95669","url":null,"abstract":"<p><p>Not required for Clinical Vignette.</p>","PeriodicalId":93990,"journal":{"name":"Endokrynologia Polska","volume":" ","pages":""},"PeriodicalIF":0.0,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"138296822","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
相关产品
×
本文献相关产品
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信